Enzo Biochem, Inc.
ENZB · OTC
4/30/2025 | 1/31/2025 | 10/31/2024 | 7/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,402 | $7,334 | $6,213 | $7,526 |
| % Growth | -12.7% | 18% | -17.4% | – |
| Cost of Goods Sold | $3,918 | $3,549 | $3,681 | $4,306 |
| Gross Profit | $2,484 | $3,785 | $2,532 | $3,220 |
| % Margin | 38.8% | 51.6% | 40.8% | 42.8% |
| R&D Expenses | $504 | $479 | $562 | $607 |
| G&A Expenses | $5,369 | $4,908 | $4,882 | $7,805 |
| SG&A Expenses | $5,369 | $4,558 | $4,882 | $7,805 |
| Sales & Mktg Exp. | $0 | -$350 | $0 | $0 |
| Other Operating Expenses | $0 | $350 | $710 | -$2,632 |
| Operating Expenses | $5,873 | $5,387 | $6,154 | $5,780 |
| Operating Income | -$3,389 | -$1,602 | -$3,071 | -$2,665 |
| % Margin | -52.9% | -21.8% | -49.4% | -35.4% |
| Other Income/Exp. Net | $1,015 | $354 | $0 | $1,517 |
| Pre-Tax Income | -$2,374 | -$1,248 | -$3,071 | -$1,148 |
| Tax Expense | $0 | $287 | $305 | $0 |
| Net Income | -$2,790 | -$1,535 | -$3,376 | -$13,381 |
| % Margin | -43.6% | -20.9% | -54.3% | -177.8% |
| EPS | -0.05 | -0.029 | -0.065 | -0.26 |
| % Growth | -70.1% | 54.5% | 75.2% | – |
| EPS Diluted | -0.05 | -0.029 | -0.065 | -0.26 |
| Weighted Avg Shares Out | 52,403 | 52,297 | 52,244 | 52,244 |
| Weighted Avg Shares Out Dil | 52,403 | 52,297 | 52,244 | 52,244 |
| Supplemental Information | – | – | – | – |
| Interest Income | $384 | $462 | $620 | $942 |
| Interest Expense | $0 | $0 | $0 | $197 |
| Depreciation & Amortization | $318 | $318 | $319 | $398 |
| EBITDA | -$3,071 | -$1,284 | -$2,845 | $478 |
| % Margin | -48% | -17.5% | -45.8% | 6.4% |